Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Behavioral Activation and HIV Risk Reduction for MSM With Crystal Methamphetamine Abuse

NCT01255280 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01255280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01255280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Behavioral Activation and HIV Risk Reduction for MSM With Crystal Methamphetamine Abuse
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2011
Completion date
December 31, 2013
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crystal methamphetamine abuse, crystal methamphetamine dependence